Measles IgG ELISA Kit


Human measles IgG ELISA kit is intended for analysing in-vitro quantitative levels of human IgG antibodies against measles virus (measles-IgG) using plasma or serum. This assay has a minimum analytical sensitivity limit of 1.35 U/ml.


Measles (also called rubeola), is an extremely contagious viral disease which can be transmitted by respiratory secretions. The measles virus is a negative sense, single stranded enveloped RNA virus that belongs to the Morbillivrus (Paramyxovirdae family). The virus is able to infect cells in the lungs and those that are at the back of the throat, causing symptoms such as sore throat, dry cough, a runny nose, tiny white spots inside the mouth, a high fever, red eyes and a characteristic rash. Two of the most common methods which are used for detecting measles infection are: antibody testing (IgG and IgM) and viral islation detection (RT-PCR).


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Measles antigen coated microtiter strips.
  • Cut-Off Standard (Calibrator B).
  • Positive Control (Calibrator D).
  • Weak Positive Control (Calibrator C).
  • Negative Control (Calibrator A).
  • Enzyme Conjugate.
  • Sample Diluent.
  • TMB Substrate.
  • Washing Buffer (10x).
  • Stop Solution.


The minimum detection sensitivity level of IgG antibodies to measles virus (measles-IgG) using current human measles virus IgG ELISA kit was 1.35 U/ml. The dynamic range for this assay is 1.0 – 250.0 U/ml.


– Measles Virus ELISA: IgG
– Intra-Assay-Precision: 12.5 %
– Inter-Assay-Precision: 6.9 – 15.8 %
– Inter-Lot-Precision: 2.7 – 12.2 %
– Analytical Sensitivity: 1.35 U/mL
– Recovery: 85 – 94 %
– Linearity: 75 – 129 %
– Cross-Reactivity: No cross-reactivity to Mumps and Varicella.
– Interferences: No interferences to triglycerides up to 5.0 mg/mL, hemoglobin up to 8.0 mg/mL and bilirubin up to 0.3 mg/mL.
– Clinical Specificity: 100 %
– Clinical Sensitivity: 97 %


  1. Comparison of chemiluminescent immunoassay and ELISA for measles IgG and IgM. APMIS. (2015) 123 (8): 648-51. de Ory F., et al.
  2. High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases. Clin Vaccine Immunol. (2016) 23 (8): 707-16. Sowers S.B., et al.
  3. Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods. (1999) 83 (1-2): 135-44. Nigatu W., et al.
  4. Measles virus IgG avidity assay for use in classification of measles vaccine failure in measlese limination settings. Clin Vaccine Immunol. (2012) 19 (11): 1810-7. Mercader S., et al.
  5. Electrochemical impedimetric immunosensor for the detection of measles-specific IgG antibodies after measles infections. Biosens Bioelectron. (2013) 49: 32-8. Mashazi P., et al.


  • Full Name: Measles IgG ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: 1.35 U/ml



Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford